Mounjaro Assessment Process: Your UK Guide

  • Comprehensive medical history review by qualified UK prescriber
  • Current medication compatibility assessment and interaction checks
  • Individual health circumstances evaluation including existing conditions
  • Clinical decision-making based on strict safety protocols
Start free consultation

Treatment from £144.99

Takes under 2 minutes · 100% online
Person enjoying the outdoors

Check if you're eligible

Height 175 cm
Weight 82 kg
Your BMI
26.8
Check with prescriber
Start free consultation
Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.
100% UK-based pharmacy Free advice & support Rated Excellent 2,400+ reviews
Which route suits you

Two clinically backed paths to results

A weekly GLP-1 injection or a daily capsule — each fully overseen by our UK pharmacy team, with no obligation to continue.

Treatment
Avg. weight loss
05%10%15%20%25%
Availability
Injection
Weekly pen · GLP-1
Avg. weight loss
~20%up to
Availability Available now
Pill NEW
Daily tablet · Oral GLP-1
Avg. weight loss
~17%up to
Availability Explore now
Live Pricing

Our Range

Prices update live and may change. The live table below always takes precedence.
All treatment is subject to a prescriber consultation and clinical approval.

Understanding Clinical Assessment Requirements

The Clinical Assessment Framework

Before any Mounjaro prescription can be issued in the UK, every patient must undergo a comprehensive clinical assessment conducted by a qualified healthcare professional. This structured evaluation process ensures that treatment is only prescribed where clinically appropriate and safe for the individual. The assessment goes far beyond basic eligibility checks, involving detailed examination of medical history, current health status, and individual circumstances that may affect treatment suitability.

UK-licensed prescribers follow established clinical protocols when evaluating potential Mounjaro patients. These protocols require thorough investigation of multiple health factors, ensuring that each prescribing decision is made with complete understanding of the patient's medical profile. The assessment process protects patient safety by identifying any contraindications or factors that might make treatment unsuitable.

The clinical framework used by UK prescribers incorporates both national guidance and individual clinical judgment. This dual approach ensures that while consistent standards are maintained across all assessments, each patient receives personalised evaluation appropriate to their unique circumstances. Healthcare professionals can only prescribe Mounjaro following satisfactory completion of this comprehensive assessment process.

Medical History Evaluation Process

A crucial component of the pre-prescribing assessment involves detailed medical history review. Healthcare professionals examine past and current medical conditions to identify any factors that might contraindicate Mounjaro treatment or require special consideration. This evaluation includes investigation of previous treatments, surgical history, and any ongoing medical management that could interact with the proposed treatment.

Prescribers pay particular attention to conditions that may be affected by Mounjaro or that might influence treatment outcomes. The medical history review also encompasses family medical history where relevant, helping healthcare professionals understand potential genetic predispositions or inherited conditions that could impact treatment safety or effectiveness.

Current symptoms and health concerns are thoroughly discussed during the medical history evaluation. Patients are encouraged to provide complete and accurate information about their health status, as this directly influences the prescriber's ability to make appropriate treatment decisions. Incomplete or inaccurate medical history can compromise patient safety and treatment outcomes.

Current Medication Assessment

Comprehensive medication review forms an essential part of the pre-prescribing assessment process. Healthcare professionals examine all current medications, including prescription medicines, over-the-counter treatments, and supplements, to identify potential interactions or contraindications with Mounjaro. This detailed review helps prevent adverse drug interactions and ensures treatment safety.

The medication assessment includes evaluation of dosing schedules, treatment duration, and effectiveness of current therapies. Prescribers may need to consider adjustments to existing medications or discuss alternative treatments if significant interactions are identified. This collaborative approach ensures that Mounjaro treatment integrates safely with the patient's existing medical management.

Patients taking certain medications may require additional monitoring or may not be suitable for Mounjaro treatment. The prescriber evaluates each medication individually and considers the cumulative effect of all treatments on patient safety and treatment outcomes. This thorough approach helps prevent complications and ensures appropriate clinical care.

Individual Suitability Determination

The final stage of the pre-prescribing assessment involves comprehensive evaluation of individual suitability factors. Healthcare professionals consider multiple elements including lifestyle factors, treatment goals, and ability to comply with the prescribed treatment regimen. This individualised assessment ensures that Mounjaro is only prescribed where it can be safely and effectively integrated into the patient's life.

Suitability determination also involves discussion of treatment expectations and potential outcomes. Prescribers ensure that patients understand what Mounjaro can and cannot achieve, emphasising that treatment success depends on combination with appropriate lifestyle modifications. This educational component helps set realistic expectations and promotes treatment adherence.

Healthcare professionals may determine that some individuals are not suitable for Mounjaro treatment based on their assessment findings. This decision-making process prioritises patient safety and ensures that treatment is only prescribed where clinical benefit is likely to outweigh potential risks. Alternative treatment options may be discussed where Mounjaro is deemed unsuitable.

Assessment Outcome and Next Steps

Following completion of the comprehensive assessment, the prescriber makes a clinical decision about treatment suitability. Where Mounjaro is deemed appropriate, the healthcare professional will provide detailed information about treatment expectations, monitoring requirements, and ongoing clinical care. This structured approach ensures that patients are fully informed before beginning treatment.

Patients who are assessed as suitable for Mounjaro treatment receive comprehensive guidance about the treatment process, including what to expect during the initial treatment period and how to access ongoing clinical support. Regular monitoring and review arrangements are established to ensure treatment safety and effectiveness throughout the treatment course.

For individuals who are not deemed suitable for Mounjaro following assessment, healthcare professionals discuss alternative approaches to weight management. This may include referral to other healthcare services, recommendation of alternative treatments, or guidance about lifestyle modification approaches that may be beneficial for the individual's circumstances.

NEW

GLP-1, now in adaily pill

Meet the daily GLP-1 tablet — needle-free, taken on your schedule, and prescribed by UK pharmacists. Designed for flexibility.

Join the free waitlist
Track your progress

Your journey,in your pocket

Track Now

Meet the newGLP-1 pill

  • Once-daily tablet · room-temp storage
  • No needles, no fridge
  • Up to ~15–17% in trials
How treatment works

How GLP-1 treatments help

Reduces appetite

Helps you feel fuller, sooner — so portions naturally shrink.

Curbs cravings

Quietens food noise so snacking and cravings ease off.

Slows digestion

Food stays in your stomach longer, steadying hunger between meals.

Steady blood sugar

Supports more stable glucose levels through the day.

Is GLP-1 treatment right for you?

GLP-1 medicines are powerful and prescription-only for good reason. They suit many people very well — and they aren’t appropriate for everyone. Here’s a clear, honest picture before you decide.

You may be suitable

Criteria met
BMI of 30 or higher
BMI of 27+ with weight-related conditions
Struggled to lose weight with diet alone
Ready to pair with lifestyle changes

Speak to us first

Potential risk
Pregnant, trying to conceive, or breastfeeding
History of certain thyroid cancers
Certain pancreatic or digestive conditions
Under the age of 18

Ready to start your journey?

Track your progress

Your journey, in your pocket

Track your journey

Log every dose and watch your progress build.

Download now Free to download — takes a minute to set up. App Store and Google Play

AI Meal Tracking. Built for GLP-1 Appetites.

Point your camera at any meal and in 4–6 seconds it logs the calories, macros, weight, and fullness it expects.

Never miss a dose

A daily nudge keeps you on track.

How it works

Achieve your goals in just a few simple steps.

Step 1

Start Free Consultation

Select safe UK treatments. Quick answers.

Step 2

Review By Our Clinical Team

Our expert team will use your consultation as the basis of our recommendation and communicate with you.

Step 3

Get it delivered fast

We’ll deliver direct to you, as quickly as tomorrow.

Trusted by thousands

Real people, real change

Hannah M.
Lost 2 st 4 lb in a year

“The cravings that used to run my evenings just quietened down. Having a pharmacist to message made it feel safe.”

David O.
Lost 3 st in a year

“Discreet, simple and genuinely supportive. The dose steps were explained clearly every time.”

Priya S.
Lost 1 st 9 lb in a year

“I finally feel like food isn’t the loudest thing in my head. The delivery was always discreet and on time.”

Frequently asked questions